¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2018 : 2019-01-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2018 : 2019-01-12
±³À°ÀÏÀÚ : 2019-01-12
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ±×·£µåº¼·ë ¹éµÎ(5F)  
±³À°ÁÖÁ¦ : BEST of WCLC 2018
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : KSMO1@KSMO.OR.KR      
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50,000 / ÀüÀÓÀÇ 30,000 / ±âŸ 70,000¿ø´çÀϵî·Ï : Àü¹®ÀÇ 60,000 / ÀüÀÓÀÇ 40,000 / ±âŸ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-12 Room A 08:50~09:30 Raising the Bar of Immunotherapy with Pembrolizumab  ¾ÈÁø¼®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 01-12 Room A 09:30~09:50 Lung cancer screening through imaging  ±¸Áø¸ð(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 09:50~10:10 Perspectives for lung cancer early diagnosis  ·ùÁ¤¼±(ÀÎÇÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 10:10~10:30 Advanced lung cancer  ÀÌ°æ¿ø(°æ»ó´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 10:30~10:50 RT and Immunotherapy  ³ë¿À±Ô(¾ÆÁÖ´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 10:50~11:20 Biology of the lung cancer  ½ÉÈ¿¼·(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 01-12 Room A 11:30~12:30 Latest clinical updates with denosumab in cancer patients  TBD(TBD) 
È޽Ġ01-12  12:30~13:00 Coffee Break  () 
±³À°½Ã°£ 01-12 Room A 13:00~13:20 Improving outcomes in locoregional NSCLC  ¼ÛâÈÆ(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 13:20~13:40 IO for locoregioanl NSCLC  ÀÓ¼±¹Î(ºÐ´çÂ÷º´¿ø) 
±³À°½Ã°£ 01-12 Room A 13:40~14:00 Management of N2 NSCLC  ¹ÚÀαÔ(¼­¿ï´ëÇб³º´¿ø) 
Åä·Ð 01-12  14:00~14:20 Discussion  () 
±³À°½Ã°£ 01-12 Room A 14:20~14:50 Small cell lung cancer  ¹ÚÁöÇö(°Ç±¹´ëÇб³º´¿ø) 
±³À°½Ã°£ 01-12 Room A 14:50~15:20 Mediastinal tumors  ÃÖÀ±Áö(°í·Á´ë¾È¾Ïº´¿ø) 
Åä·Ð 01-12 Room A 15:20~15:30 Discussion  () 
±³À°½Ã°£ 01-12 Room A 16:00~16:20 Immune checkpoint inhibitors, single or combination  Á¤Çö¾Ö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 01-12 Room A 16:20~16:40 Immuno-biomarker testing, controversies PD-L1, TMB, DNA markers  È«¼÷Èñ(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 01-12 Room A 16:40~17:00 How to overcome drug resistances to EGFR TKIs  ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø) 
Åä·Ð 01-12 Room A 17:00~17:10 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2018 : 2019-01-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï¼º¸ðº´¿ø ´ëÇѼҾƾ˷¹¸£±âÈ£Èí±âÇÐȸ Á¦59ȸ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐ ¿¬¼ö°­Á : 2019-01-13
´ÙÀ½±Û ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦15ȸ µ¿°è±¹Á¦Çмú´ëȸ : 2019-01-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
420 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦1ȸ ºñ¸¸Àü¹®°¡ ½ÉÈ­°úÁ¤: ºñ¸¸ Àü¹® ÀÎÁ¤ÀÇ ±³À° Part 1. : 2018-09-09 0 582 2018-08-15
419 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 2018³â Çù·Âº´ÀÇ¿ø ÀÇ»ç ¿¬¼ö°­Á : 2018-09-09 0 1,364 2018-08-15
418 ¼­¿ï Á¦1ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ESD¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 868 2018-08-15
417 ¼­¿ï Á¦11ȸ ¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ÁßȯÀÚÀÇÇÐ ¿¬¼ö°­Á Basic Concepts in Intensive Care, 2018 (BACIC 2018) : 2018-09-08 0 1,382 2018-08-15
416 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °í·Á´ëÇб³ °í°üÀý ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,106 2018-08-15
415 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-08 0 518 2018-08-15
414 ºÎ»ê ´ëÇѼ¼Æ÷º´¸®ÇÐȸ International Session of the 30th Annual Fall Meeting of the Korean Society for Cytopathology : 2018-09-08 0 599 2018-08-15
413 ºÎ»ê 2018³â ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2018-09-08 0 1,042 2018-08-15
412 ±¤ÁÖ Àü³²´ëº´¿ø Á¦ 3Â÷ Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç ¿¬¼ö°­Á : 2018-09-08 0 1,091 2018-08-15
411 ºÎ»ê ºÎ»ê´ëº´¿ø 2018³â Á¦1Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-09-08 0 1,434 2018-08-15
410 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¦6ȸ ¾ÆÁÖ ´ç´¢¹ß ¹× â»ó ½ÉÆ÷Áö¾ö : 2018-09-08 0 1,214 2018-08-15
409 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ÁßȯÀÚÀÇÇнÉÆ÷Áö¿ò ¹× ±â°èȯ±â¿öÅ©¼ó : 2018-09-08 0 739 2018-08-15
408 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-07 0 467 2018-08-15
407 ´ëÀü Ãæ³²´ëÇб³º´¿ø KMDS 2018³â °¡À»Áý´ãȸ : 2018-09-07 0 401 2018-08-15
406 °æ±â 2018³âµµ ¼º³²½Ã ¾È°úÀÇ»çȸ ½ÉÆ÷Áö¾ö : 2018-09-07 0 996 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷